Clariane SE/€CLARI
1D1W1MYTD1Y5YMAX
Capital at risk
About Clariane SE
Clariane SE is a French company specializing in care services for vulnerable individuals, operating across six European countries: France, Germany, Belgium, Italy, the Netherlands, and Spain. Its core activities are divided into three segments: long-term care, specialty care, and community care. Long-term care includes nursing homes and assisted living facilities; specialty care encompasses post-acute and rehabilitation services, mental health clinics, and home hospitalization; and community care offers shared living solutions and home care services. Founded in 2001 and formerly known as Korian, the company rebranded to Clariane SE in June 2023 and adopted the status of a purpose-driven company, emphasizing its commitment to addressing societal challenges related to aging and vulnerability. Headquartered in Paris, Clariane operates over 1,200 facilities, employing approximately 63,000 staff members. Its strategic positioning focuses on providing personalized care solutions integrated within local communities, leveraging a diversified service portfolio to meet the complex needs of an aging population. (,,)
- Ticker
- €CLARI
- Sector
- Health
- Primary listing
- PAR
- Employees
- 70,685
- Headquarters
- Paris, France
- Website
- www.clariane.com
Clariane SE Metrics
BasicAdvanced
€1.4B
118.79
€0.03
0.82
-
Price and volume
Market cap
€1.4B
Beta
0.82
52-week high
€4.88
52-week low
€3.27
Average daily volume
332K
Financial strength
Current ratio
0.841
Quick ratio
0.779
Long term debt to equity
1.773
Total debt to equity
2.131
Dividend payout ratio (TTM)
696.84%
Interest coverage (TTM)
1.60%
Profitability
EBITDA (TTM)
640.305
Gross margin (TTM)
31.28%
Net profit margin (TTM)
0.23%
Operating margin (TTM)
9.38%
Effective tax rate (TTM)
22.35%
Revenue per employee (TTM)
€80,000
Management effectiveness
Return on assets (TTM)
2.18%
Return on equity (TTM)
0.67%
Valuation
Price to earnings (TTM)
118.792
Price to revenue (TTM)
0.265
Price to book
0.39
Price to tangible book (TTM)
-0.85
Price to free cash flow (TTM)
1.674
Free cash flow yield (TTM)
59.75%
Free cash flow per share (TTM)
2.374
Growth
Revenue change (TTM)
0.84%
Earnings per share change (TTM)
-119.30%
3-year revenue growth (CAGR)
4.18%
10-year revenue growth (CAGR)
6.78%
3-year earnings per share growth (CAGR)
23.06%
10-year earnings per share growth (CAGR)
-24.00%
Bulls say / Bears say
Organic revenue grew by 4.5% in 2025, underpinned by resilient demand and pricing power in long-term and community care segments. (Reuters)
Pre-IFRS 16 EBITDA margin improved to 12.5% in H2 2025 from 9.9% in H1, slightly surpassing its mid-year target of ~12%, reflecting operational efficiencies. (Reuters)
Successfully priced €500 million of senior notes due 2031 in April 2026, with strong oversubscription, demonstrating continued debt market access for refinancing. (Reuters)
Pre-IFRS 16 EBITDA growth of 3.1% in 2025 lagged organic revenue growth, indicating margin pressure from inflation and funding reforms. (Reuters)
An EBITDA margin below 10% (9.9%) in the first half of 2025 underscores uneven profitability and reliance on second-half recovery. (Reuters)
Issuance of high-yield senior notes highlights exposure to elevated borrowing costs and refinancing risk in a rising interest rate environment. (Reuters)
Data summarised monthly by Lightyear AI. Last updated on 23 Aug 2026.
Upcoming events
No upcoming events
Funds containing Clariane SE
AllEURGBPUSD
Fund name | Fund size | €CLARI weighting |
|---|---|---|
iShares Ageing Population€AGED | €822M | 0.06% |
Xtrackers MSCI Europe Small Cap€DX2J | €3.2B | 0.03% |
Xtrackers MSCI Europe Small Cap£XXSC | £2.8B | 0.03% |
Vanguard ESG Global All Cap£V3AB | £905M | 0.00% |
Vanguard ESG Global All Cap€V3AA | €1.1B | 0.00% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.